Distribution and prognostic value of histopathologic data and immunohistochemical markers in gastrointestinal stromal tumours (GISTs): An analysis of the EORTC phase III trial of treatment of metastatic GISTs with imatinib mesylate.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples